This prestigious competition showcases the most promising startups transforming digital health
We are thrilled to announce that Aisthesis Medical has been selected as a finalist in the Pre-Revenue category for the Rewired25 Pitchfest, taking place at Digital Health Rewired 2025!
This prestigious competition showcases the most promising startups transforming digital health, providing a platform for groundbreaking solutions to gain visibility, funding, and industry support.
Our Mission: Revolutionizing Sepsis Detection
At Aisthesis Medical, we are pioneering VIOSync, an AI-driven clinical decision support system designed to detect sepsis earlier, improve patient outcomes, and reduce the global burden of sepsis. Being selected as a Pitchfest finalist is a testament to the impact and potential of our work.
Why This Matters
Sepsis affects millions worldwide, and early detection is critical to saving lives.
AI-driven solutions like VIOSync can enhance clinical decision-making and reduce healthcare costs.
Events like Rewired25 Pitchfest provide startups with the opportunity to connect with investors, clinicians, and healthcare leaders to accelerate innovation.
What’s Next
We look forward to connecting with key industry players, investors, and fellow innovators during this event. This is a unique opportunity to showcase our work, exchange insights, and drive forward the next era of AI in Healthcare. We’re looking forward to pitching at Rewired25, showcasing our work, and collaborating with industry leaders to push the boundaries of digital health innovation.
A huge thank you to Digital Health for creating opportunities that empower startups to scale impactful solutions.
Additional details about the event are available at Digital Health Rewired Pitchfest 2025.
Join us at Rewired25 and follow our journey!
About Aisthesis Medical
Aisthesis Medical is a deep-tech medtech startup developing cutting-edge AI-driven solutions to revolutionize acute care. Founded in 2022, our mission is to save lives by predicting and preventing sepsis before it becomes fatal. Aisthesis Medical is revolutionizing acute care with VIOSync, the first holistic AI-driven sepsis care platform that goes beyond early prediction to guide clinical intervention and optimize patient outcomes. VIOSync, predicts sepsis up to 48 hours earlier, integrates directly into hospital workflows, and optimizes treatment pathways to reduce unnecessary antibiotic use.